ADIM
LEA icon

Alpha DNA Investment Management’s Lear LEA Stock Holding History

Alpha DNA Investment Management’s Portfolio LEA Stock Details LEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,660
Closed -$418K – 224
2024
Q2 		$418K Buy
3,660
+928
+34% +$119K 0.16% 150
2024
Q1 		$396K Buy
+2,732
New +$374K 0.15% 167

Other funds holding LEA

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Alpha DNA Investment Management's LEA Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Lear (LEA) in Q3 2024, closing a stake of 3,660 shares — an estimated $418K sold.

Alpha DNA Investment Management first reported a position in LEA in Q1 2024 and held it in 2 quarters. The position peaked at $418K in Q2 2024. 434 funds tracked by Wall St. Rank hold LEA as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Lear position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,660 Lear shares in Q3 2024, an estimated $418K.
  • Alpha DNA Investment Management first reported a position in Lear in Q1 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's Lear position peaked at $418K in Q2 2024.
  • 434 funds tracked by Wall St. Rank held Lear as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.